Pagina 22 - I migliori medici di Risonanza magnetica di un'area - TOP-562medici

Il medico si è laureato presso la Facoltà di Medicina dell'Università di Ankara nel 1992 ed è diventato Specialista in Medicina presso la Facoltà di Medicina dell'Università di Uludağ, Dipartimento di Malattie Infantili. Nel 2002, il medico ha servito come Professore Assistente in Ematologia Pediatrica presso la stessa istituzione.<\/p>

Il medico è specializzato nella diagnosi e nel trattamento dei tumori infantili, della leucemia (linfoma), delle malattie emorragiche infantili, dell'occlusione vascolare, dei trattamenti per l'anemia e delle carenze di ferro e vitamine.<\/p>

Con un forte background accademico, il medico ha pubblicato 15 articoli su riviste internazionali con revisione paritaria, ha presentato 9 testi completi a incontri scientifici internazionali, ha scritto 3 libri o capitoli di libri e ha pubblicato 8 articoli su riviste locali con revisione paritaria.<\/p>

MEDICAL INTERESTS 

• Robotic knee and hip replacement surgery 

• Prosthesis revision surgery 

• Deformity (leg curvatures) 

• Shoulder and elbow diseases 

• Joint and cartilage injuries 

• Hip, knee and foot diseases 

• Arthroscopy 

• Trauma (fracture, dislocation, soft tissue injuries)

Education 

• Graduation, Marmara University Faculty of Medicine (Eng.) 

• Specialty Training, Bezmialem Foundation University Faculty of Medicine Department of Orthopedics and Traumatology 

• Maltepe University Faculty of Medicine Hand and Upper Extremity Surgery Fellowship Program  Director: Prof. Dr. Hakan Gündeş) 

• Orthopedic Trauma Research Assistant, Yale University, Department of Orthopedics and Rehabilitation 

• The EFFORT Spring Traveling Fellowship in Germany 

• Master’s Degree, University of Health Science, Hamidiye Health Sciences Institute, Advanced Joint Surgery Master’s Program,, Istanbul

Areas of Interests

• Demyelinating Diseases and MS
• Peripheral Neuropathy and Motor Neuron Disease (ALS)
• Neuromuscular Junction Diseases (MG)

Education 

• M.Sc. Faculty of Medicine, Ondokuz Mayıs University  1990
• Specialization in Medicine  Neurology,  Ankara Training and Research Hospital 1997
• Minor Specialization  Clinical Neurophysiology, Medical Specialization Board 2011

Experience

• Doctor MoH Kastamonu and Samsun Health Center No. 7 1990-1992
• Dr. Res.Assist. Ankara Training and Research Hospital Neurology Clinic 1992-1997
• Assoc. Dr. Abant İzzet Baysal University Düzce Faculty of Medicine 1999-2006
• Assoc.Dr. Duzce University Faculty of Medicine 2007-2011
• Prof.Dr  Duzce University Faculty of Medicine  2011-

Il medico ha completato la formazione di specializzazione in Oncologia Radioterapica presso la Facoltà di Medicina dell'Università di Marmara dal 2012 al 2016. Prima di questo, il medico ha completato una laurea in Medicina, insegnata in inglese, presso la stessa istituzione dal 2004 al 2011. Il medico ha una solida base nell'educazione medica, iniziando con l'istruzione superiore presso la Scuola Numero Sedici di Shirvan in Azerbaigian dal 1998 al 2004.<\/p>

Areas of Interests

• Breast cancer
• Lung cancer
• Colorectal cancers
• Gynecological and urogenital cancers
• Molecular Oncology

Education:

• Kızıltepe Anatolian High School 2001
• Dicle University Faculty of Medicine 2007
• Istanbul Medeniyet University Göztepe Training and Research Hospital 2014
• Kartal City Hospital 2021
• Associate Professor of Medical Oncology 2023

Experience:

• Liv Hospital Ulus
• Adıyaman University Training and Research Hospital
• Istanbul Umraniye Training and Research Hospital
• Istanbul Umraniye Training and Research Hospital

Research:

• Phase II, Randomized, Open-Label, Multicenter Study to Comparatively Evaluate the Efficacy and Safety of GDC-9545 and Physician-Preferred Endocrine Monotherapy in Previously Treated, Estrogen Receptor Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer Patients, Other ( International), Dr. Murat Ayhan
• Phase III, Randomized, Evaluating the Efficacy and Safety of Palbociclib and Fulvestrant with Gdc-0077 Compared with Placebo in Patients with Pik3ca-Mutant, Hormone Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer. Double Blind, Placebo Controlled Study, Other (International), Dr. Murat Ayhan
• Randomized, Multicenter, Phase Ib/III Study Evaluating the Pharmacokinetics, Efficacy, and Safety of Subcutaneous Atezolizumab Compared to Intravenous Atezolizumab in Patients with Previously Treated Locally Advanced or Metastatic Non-Small Cell Lung Cancer, Other (International) Dr. Murat Ayhan
• Randomized, Controlled, Multicenter, Open-Label Study Including Observation Follow-Up for PSMA-PET-Negative Patients, Investigating the Efficacy and Safety of Addition of Apalutamide to Radiotherapy and LHRH Agonist in PSMA-PET-Positive High-Risk Hormone-Sensitive Prostate Cancer Patients, Other (International) Dr. Murat Ayhan
• Biomarker Study to Identify Patients with Advanced Stage Urothelial Cancer and Fibroblast Growth Factor Receptor Gene Aberrations-42756493BLC0002, Other (International), Dr. Murat Ayhan
• Publications:
• Ayhan M, Turan N, Köstek O, et all. Does the efficacy of regorafenib differ in chemotherapy refractory metastatic colorectal cancer patients who had mucinous pathology compared to those who had non-mucinous pathology? Curr Probl Cancer. 2021 Jun;45(3):100670. doi: 10.1016/j.currproblcancer.2020.100670.
• Ayhan M, Odabas H, Turan N, et all. Factors affecting the mortality rate of patients with cancer hospitalized with COVID-19: a single center's experience. J Chemother. 2021 Nov;33(7):499-508. doi: 10.1080/1120009X.2021.1923153.
• Ayhan M, Laçin Ş, Özyükseler DT, et all. Does systemic anti-tumor therapy increase COVID-19 risk in patients with cancer? J Oncol Pharm Pract. 2021 Sep;27(6):1461-1467. doi: 10.1177/10781552211015762.
• Ayhan M, Abamor E, Coban Kokten S, et al. Value of FDG PET/CT in Predicting Pathologic Complete Response After Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer. EJMI 2022;6(2):165–175.
• Ayhan M, Terzioglu K. Experience With Rapid Drug Desensitization With Chemotherapeutics; A SingleCentre Retrospective Study. EJMI 2021;5(3):380–387.
• Doğan A, AYHAN M. Survival analysis of patients with triple-negative breast cancer: a single-center experience. Journal of Oncological Sciences, 8(2), 94-99., Doi: 10.37047/jos.2022-89749
• Terzioğlu K, Ayhan M. Comparative Assessment of Platinum Salts and Taxane Group Hypersensitivity Reactions, The Role of Skin Tests in Diagnosis? J Oncol Pharm Pract. 2021 Nov 30:10781552211050084. doi: 10.1177/10781552211050084.
• Tacar SY, Selcukbiricik F, Yilmaz M, Erturk K, Murat Sarici A, Gulturk I, Ayhan M, Tural D. Nivolumab for metastatic uveal melanoma: a multicenter, retrospective study. Melanoma Res. 2021 Oct 1;31(5):449-455. doi: 10.1097/CMR.0000000000000744.
• Özyurt E, Özçelik S, Sürmeli H, Çelik M, Ayhan M, Özçelik M. Side effects of immune-checkpoint inhibitors: Can multiple side effects be seen in a patient? J Oncol Pharm Pract. 2022 Mar;28(2):462-465. doi: 10.1177/10781552211038136.
• Dülgar Ö, Öven BB, Atcı MM, Arıkan R, Ay S, Ayhan M, Selvi O, Ozyukseler DT, Bayram E, Özcan E, Yasin Aİ, Gümüş M. Is the benefit of using adjuvant capecitabine in patients with residual triple-negative breast cancer related to pathological response to neoadjuvant chemotherapy? Expert Rev Anticancer Ther. 2022 Jul;22(7):773-780. doi: 10.1080/14737140.2022.2076670.
• Hizal M, Bilgin B, Paksoy N, Ayhan M, et all. The real-life efficacy and safety of osimertinib in pretreated advanced non-small cell lung cancer patients with T790M mutation: a Turkish Oncology Group Study. J Cancer Res Clin Oncol. 2022 Jun;148(6):1501-1508. doi: 10.1007/s00432-021-03748-7.
• Volume I, Kucukarda A, Atcı MM, Ayhan M, et all. Efficacy and safety of trastuzumab emtansine in older patients with HER2-positive advanced breast cancer: a real-world study. Tumori. 2022 Feb;108(1):19-25. doi: 10.1177/03008916211037739.
• Dogan I, Ayhan M, Gurbuz M, et all. The frequency and prognostic significance of ABO/Rh blood groups in male breast cancer patients: A multicenter study. Medicine (Baltimore). 2022 Sep 2;101(35):e30147. doi: 10.1097/MD.0000000000030147.
• Ozcelik M, Oyman A, Cil I, Duzgun O, Ozkan OF, Ayhan M. Cytoreductive Surgery versus Systemic Chemotherapy alone in Isolated Peritoneal Carcinomatosis of Colorectal Origin. J Coll Physicians Surg Pak. 2021 Nov;31(11):1308-1313. doi: 10.29271/jcpsp.2021.11.1308.
• Başoğlu T, Sakin A, Erol C, Ayhan M, et all. Real life experienceof patients with locally advanced gastric and gastroesophageal junction adenocarcinoma treated with neoadjuvant chemotherapy: a Turkish oncology group study. J Chemother. 2022 May 17:1-8. doi: 10.1080/1120009X.2022.2073159.
• Özdemir Ö, Zengel B, Yildiz Y, Ayhan M, et all. The effectiveness and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early-stage human epidermal growth factor receptor 2-positive breast cancer: Turkish Oncology Group study. Anticancer Drugs. 2022 Aug 1;33(7):663-670. doi: 10.1097/CAD.0000000000001310.
• Hizal M, Bilgin B, Paksoy N, Ayhan M, et all. The percentage of ALK-positive cells and the efficacy of first-line alectinib in advanced non-small cell lung cancer: is it a novel factor for stratification? (Turkish Oncology Group Study). J Cancer Res Clin Oncol. 2022 Sep 1. doi: 10.1007/s00432-022-04252-2.
• Hizal M, Bilgin B, Paksoy N, Ayhan M, et all. Real-world data on efficacy and safety of first-line alectinib treatment in advanced-stage, ALK-positive non-small-cell lung cancer patients: a Turkish Oncology Group study. Future Oncol. 2022 Jul;18(23):2573-2582. doi: 10.2217/fon-2022-0083.
• Topcu A, Atci MM, Secmeler S, Besiroglu M, Ayhan M, Ozkan M, Bozkurt O, Urakci Z, Ay S, Geredeli C, Yasin AI, Turk HM. Efficacy of trastuzumab and potential risk factors on survival in patients with HER2-positive metastatic gastric cancer. Future Oncol. 2021 Nov;17(31):4157-4169. doi: 10.2217/fon-2021-0398.
• Bilgin B, Sendur MAN, Yucel S, Ayhan M, et all. Real-life comparison of the afatinib and first-generation tyrosine kinase inhibitors in nonsmall cell lung cancer harboring EGFR exon 19 deletion: a Turk Oncology Group (TOG) study. J Cancer Res Clin Oncol. 2021 Jul;147(7):2145-2152. doi: 10.1007/s00432-020-03501-6.
• Atci MM, Akagunduz B, Demir M, Arikan R, Ay S, Ozer M, Ayhan M, Cil I, Demir N, Ozyurt N, Karakaya G, Cevik GT, Onder AH, Selvi O, Sakin A. The impact of adjuvant oxaliplatin and tumor sidedness on the overall survival of stage IIB colon cancer patients: a multicentre study. J Chemother. 2023 Feb;35(1):19-28. doi: 10.1080/1120009X.2022.2040770.
• Tataroglu Ozyukseler D, Ay S, Turan M, Alkan G, Ayhan M, Surmeli H, et al. The Systemic Inflammation Response Index as a Prognostic Marker in Advanced Pancreatic Cancer. EJMI 2022;6(3):367–373.
• Yıldız F, Ayhan M, Demir H, et all. Comparing the efficacy of cabazitaxel in secondline and third-Line treatment of metastatic castration-resistant prostate cancer: a multi-center experience from Turkey. International Journal of Contemporary Medical Research, 7(9), 112-116.,Doi: 10.21276/ijcmr.2020.7.9.30
• Terzioğlu K, Ayhan M. Distribution of allergens detected on patch tests of patients with allergic contact dermatitis and investigation of their atopic background. Annals of Medical Research, 29(5), 422-426., doi: 10.5455/annalsmedres.2021.07.490
• Arikan R, Atci MM, Ay S, Ayhan M, et all Prognostic significance of mucinous histology in left sided metastatic colorectal cancers with wild type RAS and evaluation of backbone chemotherapy regimens. Oncol Lett. 2023 Apr 5;25(5):208. doi: 10.3892/ol.2023.13795.
• Almuradova E, Yalcin S, Arıkan R, Ayhan M, Demir H, Cevik GT, Karaca M, Petekkaya I, Karabulut B. Survival of Patients With Metastatic Rectum Cancer Who Underwent Metastasectomy Following Conversion Chemotherapy Sans Pelvic Radiotherapy: A Turkish Oncology Group Study. Cureus 2023 May 17;15(5):e39119. doi: 10.7759/cureus.39119.
• Topcu A, Besiroglu M, Atci MM, Ayhan M, et all. Second-line Therapy after Trastuzumab Failure in HER2-Positive Metastatic Gastric Cancer: A Real-life Data. EJMI 2023;7(2):153–161. DOI: 10.14744/ejmi.2023.22720
• Book Writing:
• Drug interactions and side effects of targeted agents, Section name: (Small molecule tyrosine kinase inhibitors; ROS-1 targeted therapies (Crizotinib, Seritinib)) (2021)., AYHAN MURAT, Turkish Clinics Journal of Medical Sciences, Editor: Mehmet Aliustaoglu, Publishing number:1, Number of Pages 92, ISBN:978-625-401- 466-6, Turkish
• Approach to gastrointestinal stromal tumors and neuroendocrine tumors, Department name: (Medical approach in primary non-gastrointestinal neuroendocrine tumors) (2020)., AYHAN MURAT, Akademisyen Yayınevi, Editor: Anılır Ender, Number of editions: 1, Number of Pages 382, ISBN: 9786052585719, Turkish
• Internal medicine emergencies, Department name: (Oncological emergencies) (2022)., YILDIRIM SEDAT, AYHAN MURAT, Efe Academic Publishing, Editor: Serdar Olt, Number of editions: 1, Number of Pages 232, ISBN: 978-625-8324-66- 2, Turkish
• Physicians' chemotherapy cancer drug manual 2020, Section name: (Common chemotherapy regimens in clinical practice) (2022)., SÜMBÜL AHMET TANER, ALKAN ALI, AKSOY ASUDE, AYHAN MURAT, et all, Türkiye Klinikleri Journal of Medical Sciences, Editor: EDWAR CHU, VINCENT T. DEVITA, SAADDETIN KILIÇKAP, CEMIL BILIR, SELÇUK SEBER, Number of editions: 1, Number of pages 772, ISBN: 978-625-401-290- 7, Turkish (Book Translation)

Areas of Interests

• Neuro-oncological surgery
• Spinal Surgery
• Pediatric Neurosurgery
• Peripheral Nerve Surgery
• Functional Neurosurgery and Algology

Education:

• Istanbul University, Faculty of Medicine
• Istanbul Okmeydani Training and Research Hospital

Experience:

• Liv Hospital Ulus
• Sisli Kolan Hospital
• Prof.Dr.Cemil Taşcıoğlu City Hospital
• Ardahan State Hospital

Research:

• Tumor markers and other laboratory findings in brain tumors
• Antiepileptic drugs in operated brain tumors
• Cervical corpectomy techniques
• Pre-emptive analgesia in spine surgeries

Publications:

• Uysal E, Cine HS, Yavuz AY, Cal MA. Impact of subventricular zone interaction on clinical outcomes in patients with intracerebral hematoma. Experimental Biomedical Research, 2024;7(3): 117–126. https://doi.org/10.30714/j-ebr.2024.215
• Çal MA, Yangı K. A Single-center Study Comparing Volumetric and Morphometric Measurements of Chiari Malformation in the Turkish Population. Eur Arc Med Res.2024 Mar;40(1):50-56. doi:10.4274/eamr.galenos.2024.24892.
• Avcı İ, Başkurt O, Şeker S, Kurtuluş Y, Çal MA. Rapid Recurrence of Glioblastoma After 12 Days Despite Gross Total Resection. Eur Arc Med Res.2024 Mar;40(1):62-65. doi:10.4274/eamr.galenos.2024.48615.
• Play MA. The relationship between vertebral compression rates and systemic inflammatory scores in osteoporotic vertebral fractures. Eur Rev Med Pharmacol Sci. 2024;28(3):959-968. doi:10.26355/eurrev_202402_35333
• Çal MA, Gök H. Retrospective Evaluation of the Effect of Surgery and CyberKnife on Recurrence and Neurological Deficits in Cases Diagnosed as Vestibular Schwannoma. Haydarpasa Numune Med J.2023;63 (1), 62 ‑67.doi:10.14744/hnhj.2022.45712
• Uysal E, Çal MA, Cine HS. The use of vancomycin powder in the compound depressed skull fractures. Clin Neurol Neurosurg. 2023;225:107570. doi:10.1016/j.clineuro.2022.107570
• Gök H, Şeker S, Peker HO, Çal MA, Altay T, Çelik S. A rare case report: Cervical subcutaneous and mediastinal emphysema due to mastoid fracture. A rare case report: Cervical subcutaneous and mediastinal emphysema due to mastoid fracture. Ulus Travma Emergency Surgery Journal . 2020;26(2):328 ‑330. doi:10.14744/tjtes.2019.02828
• Çınar N,Karaoğlan A,Midi A,Çal MA,Kelten B,Çakmak MA,Şahin Ş. Neuroprotective effect of ziprasidone: Preliminary results compared to haloperidol. J. Exp. Clin. Med ., 2014; 31:71 ‑75. doi : 10.5835/jecm.omu.31.02.002
• Karaoglan A, Cal MA, Orki A, Arpaozu BM, Colak A. Pneumorrhachis associated with bronchial asthma , subcutaneous emphysema and pneumomediastinum . Turkish Neurosurg . 2011;21(4):666 ‑668.
• Kelten B, Karaoğlan A, Cal MA, Akdemir O, Karancı T. Human immunodeficiency Bilateral epidural puncture in a patient infected with the virus Hematoma : Case report [ Bilateral epidural hematoma in a patient with Human immunodeficiency virus infection : a case report ]. Ulus Trauma Emergency Surgery Journal . 2013;19(3):267 ‑270. doi: 10.5505 /tjtes.2013.49799
• Karaoglan A, Akdemir O, Cinar N, et al. Correlation between leptin and pro- ‑inflammatory cytokines in cortical contusion injury model. Ulus Trauma Emergency Surgery Journal . 2011;17(4):298 ‑302. doi: 10.5505 /tjtes.2011.69077
• Cal MA, Kelten B, Akbas A, Akdemir O, Karaoglan A. Coexistence of spinal lipoma, ependymal cyst and dermoid cyst in neighboring localizations in context medullaris : A case report . HealthMed . 2013; 7(12):3227
• Canpolat A, Duman H, Akbaş A, Çal MA, Akdemir AO. Diffuse dysphagia and myeloradiculopathy presenting idiopathic skeletal hyperosteosis ( Forestier Disease). TC Maltepe University Medical Faculty Journal.2012;4(2),14 ‑17
• Karaoglan A, Kelten B,Akdemir AO,Çal MA. Lumbar spine presenting with radiculopathy spinal Chondroma : Case report. TC Maltepe University Medical Faculty Journal. 2011;3(3),28 ‑30
•  
• Istanbul Medical Chamber
• Turkish Neurosurgery Association
   

Areas of Interests

• Pediatric Genitourinary Reconstrictive Surgery
• Hypospadias
• Circumssion
• Oncological Surgery
• Congenital Abnormalities of Upper and Lower Urinary System
• Newborn Surgery
• Pediatric Abdominal Surgery

Education
 

• 1997 -  19 Mayıs University
• 1998 National Pediatric Surgery Congress Best Reearch Study
• 2001-  Kocaeli University
• 2007 – Kosova Government
• 2009 – Yeditepe University
• 2009 – Suudi Arab be Congeress Best Clinical Study

Experience
 

• FMV Işık Highschool
• İstanbul University Cerrahpaşa Medical Faculty
• Ondokuz Mayıs University
• Zeynep Kamil Childrens Hospital
• Kocaeli University Medical Faculty
• UT Southwestern Medical Center Pediatric Urology, Dallas, USA
• Ege University Medical Center Pediatric Urology
• Yeditepe University

Prof. Dr. Selami Sozubir has authored 65 scientific publications, which have received over 11,000 reads and nearly 1,000 citations, reflecting his strong contribution to the field of pediatric surgery and urology.

Areas of Interests

• General Neurology
• Clinical Neurophysiological examinations (Electromyography, evoked potentials, electroencephalography, polysomnography)
• Peripheral Nervous System Diseases
• Muscle diseases
• Epilepsy
• Headache
• Sleep and sleep disorders
• Migraine botox and botulinum A toxin applications

Education:

• 1980-1985 Atatürk Elementary School
• 1985-1988 Anamur High School
• 1988-1991 Anamur High School
• 1991-1998 Marmara University Faculty of Medicine in English
• 2000- 2004 PTT Education and Research Hospital Neurology Clinic (Medical Specialization Student)
• 2007-2010 Istanbul University Health Sciences Experimental Medicine Research Institute Electroneurophysiology Master's Program
• 2012- Clinical Neurophysiology Sub-branch Specialist

Experiences:

• September 2023-Currently Haliç University Faculty of Medicine, Faculty Member
• January 2023-Currently Hisar Intercontinental Hospital, Department of Neurology
• 2014- August 2023 Bilgi University Health Sciences Vocational School Electroneurophysiology Department, Faculty Member
• 2019- 2022 Ataşehir Private Avicenna Hospital, Neurology Department
• 2009-2018 Fatih Sultan Mehmet Education and Research Hospital Neurophysiology Laboratory (Specialist Doctor)
• 2007-2010 Istanbul University Health Sciences Experimental Medicine Research Institute Electroneurophysiology Master's Program
• 2005-2006 Istanbul University Istanbul Faculty of Medicine Department of Neurology Electrodiagnostics Department EMG Laboratory
• 2000-2004 PTT Education and Research Hospital Neurology Clinic (Specialist Student in Medicine)

Dr. Lechanoine is a highly accomplished neurosurgeon with extensive international experience, currently serving as a senior consultant at Maria Cecilia Hospital in Italy. With over 2,500 surgeries performed, including 1,600 as the lead surgeon, Dr. Lechanoine has built a distinguished career specializing in complex brain and spine surgeries. His areas of expertise include brainstem conditions, intraventricular neuroendoscopy for hydrocephalus and tumors, transsphenoidal surgery for pituitary adenomas, and minimally invasive spine procedures such as UBE (Unilateral Biportal Endoscopy).

His medical journey has taken him across Europe and beyond, with positions at prestigious institutions such as CHU de Grenoble Alpes and CHRU de Tours in France, and Ospedale Santobono in Naples, Italy. In addition, his dedication to pediatric neurosurgery has led to international collaborations, including at the General Peltier Hospital in Djibouti and the Meyer Children’s Hospital in Florence.

Dr. Lechanoine’s education is equally impressive. He graduated in Medicine and Surgery from the University of Caen, France, in 2012 and specialized in neurosurgery at the University of Tours under the guidance of renowned professors Stéphane Velut and Patrick François. His specialization focused on innovative endoscopic treatments for intracranial arachnoid cysts in children. Throughout his career, Dr. Lechanoine has pursued numerous advanced training courses, earning prestigious certifications, including the Diploma of the European Association of Neurosurgical Societies (EANS) and the European Diploma of Spine Surgery (Eurospine).

In addition to his clinical work, Dr. Lechanoine has contributed significantly to the field of neurosurgery through research and education. He has authored numerous scientific publications in leading international journals, with a total impact factor of 71.46. He is also a dedicated educator, serving as a tutor at international workshops on brain and spine endoscopy, and he recently founded a UBE surgical training center at Maria Cecilia Hospital.

Education

Cumhuriyet University Faculty of Medicine, 2004
Istanbul Haydarpaşa Training and Research Hospital Internal Medicine Residency, 2010
Karadeniz Technical University Faculty of Medicine Medical Oncology Residency, 2015

Experience

MD Andeson Cancer Center, USA, 2008
Sunnybrook Odette Cancer Center Breast Cancer Clinic, Canada, 2017
Moffit Cancer Center , USA 2022
Istanbul Haydarpaşa Training and Research Hospital Internal Medicine, 2010
İdil State Hospital Internal Medicine Clinic, 2011
Karadeniz Technical Universityniversitesi Faculty of Medicine, Medical Oncology Clinic, 2015
Istanbul Göztepe Training and Research Hospital, Medical Oncology Clinic, 2018
Yeniyüzyıl University Gaziosmanpaşa Hospital, Medical Oncology Clinic, 2020
Ataşehir Medicana Hospital, Medical Oncology Clinic, 2022

Scientific Membership

Turkish Medical Association (TTB)
Turkish Society of Medical Oncology (TTOD)
European Society for Medical Oncology (ESMO)
American Society of Medical Oncology (ASCO)

Medical Intrests

• Breast Cancer
• Lung Cancer
• Colon Cancer
• Stomach Cancer
• Rectal Cancer
• Ovarian Cancer
• Liver Cancer
• Oesophageal Cancer - Oesophageal Cancer
• Kidney Cancer
• Larynx Cancer - Cancer of the Larynx
• Thyroid Cancer
• Head and Neck Cancers
• Gynaecological Cancers
• Pancreatic Cancer
• Oesophageal Cancer - Oesophageal Cancer
• Uterine Cancer
• Brain Cancers - Brain Tumours
• Soft Tissue Cancer - Sarcomas
• Prostate Cancer
• Bladder Cancer
• Bile Tract Cancer
• Testicular Cancer
• Cervical Cancer
• Mouth, Tongue, Lip Cancers
• Gastrointestinal System Cancers
• Bone Tumours
• Trachea and Bronchial Cancers
• Skin Cancers - Skin Cancers
• Skeletal System Tumours
• Gallbladder Cancer
• Mesothelioma

Education

Undergraduate: Faculty of Medicine, Istanbul University Cerrahpaşa Faculty of Medicine, 2000-2006
MSc/Medical Specialization: Pediatrics, Şişli Etfal Training and Research Hospital, 2007-2012
PhD/Subspecialization in Medicine: Child Neurology, Medipol University, 2014-2017

Experience

Medical Specialization Research Assistant: Department of Physiology, Istanbul University Çapa Faculty of Medicine, 2006-2007
Specialist Doctor/State Service Obligation: Pediatrics, Sanliurfa Suruc State Hospital, 2012-2014
Subspecialty Specialist/Public Service Obligation: Pediatric Neurology, Istanbul Gaziosmanpaşa Training and Research Hospital, 2017-2020
Subspecialty Specialist Doctor/Dr. Faculty Member: Child Neurology, Istinye University Hospital, 2020-2024

Scientific Memberships
 

Turkish Medical Association
Child Neurology Association of Turkey

Medical Intrests

• Epilepsy
• Fiery Remittance
• Treatment of Resistant Epilepsy
• Sleep Disorders
• Cerebral Palsy
• Risky Baby Monitoring
• Speech Delay
• Walking Delay
• Autism
• Headache
• Migraine
• Neurological Developmental Delay

Education

• Faculty of Medicine: Trakya University, 1982-1988
• Radiation Oncology Residency: Şişli Etfal Training and Research Hospital, 1994-1998
• Radiation Oncology Residency: Princess Margaret Hospital Toronto, 1996
• Phytotherapy Master's Degree: Istanbul University Faculty of Pharmacy, 2017-2018

Experience

• Professor, Head of Department: Health Sciences University Bursa Faculty of Medicine, Department of Radiation Oncology, 2021-2024
• Professor, Head of Department: Health Sciences University Izmir Faculty of Medicine, Department of Radiation Oncology, 2021-2024
• Professor: Department of Radiation Oncology, Health Sciences University Istanbul Hamidiye Faculty of Medicine, 2021-2024
• Lecturer Gelisim University SMYO, 2013-2020

Medical Interests

• Breast Cancer / Intraoperative Radiotherapy
• Gynaecological Cancers / Brachytherapy Applications
• Gastrointestinal System Tumours
• Prostate Cancer / Hydrogel Space Oar Certificate and Application
• Lung Cancers
• Brain Tumours
• Head and Neck Cancers

Professor Dr. Cenap Zeybek is a respected Pediatric Cardiologist known for his skill in advanced heart procedures. He became an Associate Professor in 2011. In 2017, he was promoted to Professor. This shows his expertise and leadership in pediatric cardiology. Dr. Zeybek has performed many complex surgeries, such as heart valve replacements, open heart operations, and interventional procedures. His work has helped improve outcomes for children with heart conditions.

He has published many scientific articles and given several presentations. This shows his dedication to improving pediatric heart care. Dr. Zeybek’s qualifications and academic success make him a leading expert in his field.

Il medico è specializzato in disturbi neurologici, concentrandosi sul trattamento e la riabilitazione. L'esperienza include la gestione dell'epilessia, dei disturbi del sonno, delle cefalee, delle malattie cerebrovascolari e dei problemi di movimento.<\/p>

Education

GATA Faculty of Medicine, Doctor of Medicine Education, 1984, Ankara/Istanbul
GATA Faculty of Medicine, Neurology Residency, 1992, Ankara/Istanbul

Experience

GATA Neurology Department Specialization Student (1987-1992, Ankara/Turkey)
GATA Neurology Department Assistant Professor (1992-1995, Ankara/Turkey)
KüTahya Air Hospital Neurology Specialist and Chief Physician (1995-2003, Kütahya/Turkey)
Şişli Memorial Hospital Neurology Specialist (2004-2021, Istanbul/Turkey)

I completed my primary, secondary and high school education in Konya, my hometown, and my medical school and medical specialty education in Ankara GATA. I received flight medicine training and worked as a flight physician in the military and civilian sectors. I received beginner and advanced photography training and opened 4 photography exhibitions. I have made photography studies in 56 countries in Turkey and in 56 countries that I had the opportunity to visit.

Scientific Memberships

Turkish Medical Association
DGCA Health Board Membership

Education

Undergraduate: Medicine, Istanbul University Istanbul Faculty of Medicine, 2004-2010
Ph: Orthopedics and Traumatology, Bezmialem Vakif University Faculty of Medicine, 2011-2016

Hakkari Yüksekova State Hospital (2016 - 2017, State Service Yüas Deputy Chief Physician)
Department of Orthopedics and Traumatology, Biruni University Faculty of Medicine (2017 - present)
Head of Department of Orthopedics and Traumatology, Biruni University Faculty of Medicine (2018 - present)

Experience

General Practitioner, Muş Merkez Azize Hersat Health Center (DHY), 2010-2010
General Practitioner, Muş Varto State Hospital Emergency Department (DHY), 2010-2010
General Practitioner, Muş State Hospital Emergency Department (DHY), 2010-2011
Assistant Physician, Bezmialem Vakıf University Faculty of Medicine, 2011-2016
Specialist Physician (Op. Dr.), Hakkari Yüksekova State Hospital (DHY), 2016-2017
Dr. Assoc. Member, Biruni University Faculty of Medicine Hospital, 2017 (currently)

Education

University of Wisconsin Clinic of Neurosurgery (2017, Madison/USA)
Bakırköy Psychiatric Hospital (2014, Istanbul/Turkey)
Mersin University Faculty of Medicine (2007, Mersin/Turkey)

Experience

Istanbul Kanuni Sultan Süleyman Training and Research Hospital (2014-2021, Istanbul/Turkey)
Istanbul Bakırköy Mental and Neurological Diseases Hospital (2008-2014, Istanbul/Turkey)
Çorlu State Hospital (2007-2008, Çorlu/Turkey)

• In 2014, I completed my specialty training in the Department of Neurosurgery at Istanbul Bakırköy Prof. Dr. Mazhar Osman Mental Health and Neurological Diseases Training and Research Hospital and started to work as a specialist in Neurosurgery at Istanbul Health Sciences University Kanuni Sultan Süleyman Training and Research Hospital,
• In 2017, I was a visiting scholar at the University of Wisconsin Department of Neurosurgery/ Madison USA.
• In 2021, I received the title of associate professor.
• In December 2021, I left Kanuni Sultan Süleyman Training and Research Hospital, where I worked for 7.5 years, and started working at Biruni University Hospital.
•  

Scientific Memeberships

Turkish Neurosurgical Society
Turkish Spine Society
EUROSPINE
Turkish Medical Association